HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miguel Angel Basombrío Selected Research

TAK 187

4/2005Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miguel Angel Basombrío Research Topics

Disease

3Infections
12/2011 - 12/2002
3Chagas Disease (American Trypanosomiasis)
09/2010 - 11/2004
1Cutaneous Leishmaniasis
12/2011
1Body Weight (Weight, Body)
09/2010
1Latent Infection
12/2002
1Parasitemia
12/2002

Drug/Important Bio-Agent (IBA)

3benzonidazole (benznidazole)IBA
09/2010 - 12/2002
2AntibodiesIBA
11/2004 - 12/2002
1AntigensIBA
12/2011
1SolventsIBA
09/2010
1Pharmaceutical PreparationsIBA
09/2010
1hydroxymethylnitrofurazoneIBA
09/2010
1Nitrofurazone (Nitrofural)FDA Link
09/2010
1EnzymesIBA
06/2005
1ImmunosorbentsIBA
06/2005
1Ergosterol (Lumisterol)IBA
04/2005
1TAK 187IBA
04/2005
1DNA (Deoxyribonucleic Acid)IBA
12/2002

Therapy/Procedure

1Immunotherapy
12/2011